These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27849192)

  • 1. Minimed 670G: a hybrid closed-loop insulin delivery system.
    Med Lett Drugs Ther; 2016 Nov; 58(1508):147-148. PubMed ID: 27849192
    [No Abstract]   [Full Text] [Related]  

  • 2. Review of a commercially available hybrid closed-loop insulin-delivery system in the treatment of Type 1 diabetes.
    Stone JY; Haviland N; Bailey TS
    Ther Deliv; 2018 Feb; 9(2):77-87. PubMed ID: 29235423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes.
    Jendle J; Pöhlmann J; de Portu S; Smith-Palmer J; Roze S
    Diabetes Technol Ther; 2019 Mar; 21(3):110-118. PubMed ID: 30785311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose control during Ramadan fasting in a teenager with type 1 diabetes on MiniMed 670G hybrid closed-loop system.
    Petrovski G; Al Khalaf F; Campbell J; Hussain K; Fisher H; Umer F
    Acta Diabetol; 2020 Jan; 57(1):105-107. PubMed ID: 31473833
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System.
    Messer LH; Forlenza GP; Sherr JL; Wadwa RP; Buckingham BA; Weinzimer SA; Maahs DM; Slover RH
    Diabetes Care; 2018 Apr; 41(4):789-796. PubMed ID: 29444895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose sensors: toward closed loop insulin delivery.
    Chia CW; Saudek CD
    Endocrinol Metab Clin North Am; 2004 Mar; 33(1):175-95, xi. PubMed ID: 15053902
    [No Abstract]   [Full Text] [Related]  

  • 7. Perioperative Use of a Hybrid Closed Loop System in an Obese Patient With Type 1 Diabetes Undergoing Metabolic Surgery: Insights Into Changes in Insulin Delivery and Sensitivity.
    Rodriguez-Diaz E; Rizo I; Sullivan C; Steenkamp DW
    J Diabetes Sci Technol; 2018 Nov; 12(6):1239-1240. PubMed ID: 29957042
    [No Abstract]   [Full Text] [Related]  

  • 8. Fast-acting insulin aspart (Fiasp®) improves glycemic outcomes when used with MiniMed
    Grosman B; Wu D; Parikh N; Roy A; Voskanyan G; Kurtz N; Sturis J; Cohen O; Ekelund M; Vigersky R
    Comput Methods Programs Biomed; 2021 Jun; 205():106087. PubMed ID: 33873075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INTEGRATED INSULIN PUMP AND CONTINUOUS GLUCOSE MONITORING TECHNOLOGY IN DIABETES CARE TODAY: A PERSPECTIVE OF REAL-LIFE EXPERIENCE WITH THE MINIMED
    Aleppo G; Webb KM
    Endocr Pract; 2018 Jul; 24(7):684-692. PubMed ID: 30048171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appearance of Do-It-Yourself closed-loop systems to manage type 1 diabetes.
    Hng TM; Burren D
    Intern Med J; 2018 Nov; 48(11):1400-1404. PubMed ID: 30387315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-World, Patient-Reported and Clinic Data from Individuals with Type 1 Diabetes Using the MiniMed 670G Hybrid Closed-Loop System.
    DuBose SN; Bauza C; Verdejo A; Beck RW; Bergenstal RM; Sherr J;
    Diabetes Technol Ther; 2021 Dec; 23(12):791-798. PubMed ID: 34524023
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges for outpatient closed loop studies: how to assess efficacy.
    Beck RW; Calhoun P; Kollman C
    Diabetes Technol Ther; 2013 Jan; 15(1):1-3. PubMed ID: 23297669
    [No Abstract]   [Full Text] [Related]  

  • 13. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CGMs and insulin pumps. Is this dynamic duo the right choice for you?
    Neithercott T
    Diabetes Forecast; 2013 Jan; 66(1):48-55. PubMed ID: 23373086
    [No Abstract]   [Full Text] [Related]  

  • 15. Trend Spotting. What's new and what's on one device user's wish list.
    Farrell B
    Diabetes Forecast; 2013 Jan; 66(1):30-3. PubMed ID: 23367690
    [No Abstract]   [Full Text] [Related]  

  • 16. Tools of the trade 2012.
    Cooper AA
    Diabetes Self Manag; 2012; 29(6):30, 32-4, 36-8 passim. PubMed ID: 23330471
    [No Abstract]   [Full Text] [Related]  

  • 17. A real-world study of user characteristics, safety and efficacy of open-source closed-loop systems and Medtronic 670G.
    Jeyaventhan R; Gallen G; Choudhary P; Hussain S
    Diabetes Obes Metab; 2021 Aug; 23(8):1989-1994. PubMed ID: 33999488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of continuous glucose monitoring data to assess outpatient closed-loop studies: considerations for different sensors.
    Mitre TM; Legault L; Rabasa-Lhoret R; Haidar A
    Diabetes Technol Ther; 2014 May; 16(5):326-7. PubMed ID: 24447013
    [No Abstract]   [Full Text] [Related]  

  • 19. Closed loop insulin delivery in diabetes.
    Battelino T; Omladič JŠ; Phillip M
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):315-25. PubMed ID: 26051293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes advances. New management tools.
    Mayo Clin Health Lett; 2000 Aug; 18(8):4-5. PubMed ID: 10932952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.